Latest Breaking News On - ரோன் ிர்ஸ்ச்பேர்க் - Page 1 : comparemela.com

MedRhythms and Massachusetts General Hospital Launch Study of Gait Asset for Multiple Sclerosis MedRhythms announces the launch of a clinical trial, in collaboration with Massachusetts General Hospital (MGH), that will study MR-004, MedRhythms’ multiple sclerosis (MS) asset. The trial was funded by the National Multiple Sclerosis Society, aims to study the impacts of Rhythmic Auditory Stimulation on MS walking impairments. It expands on the research that is being conducted with MR-004 in a clinical trial with Cleveland Clinic that was announced in 2020. The trial will be led at MGH by Co-Principal Investigators, Dr. Eric Klawiter and Dr. Ron Hirschberg, and will be a randomized crossover trial looking at the impacts of MR-004, a digital therapeutic that digitizes Rhythmic Auditory Stimulation, on functional outcomes such as gait speed as well as neuroimaging compared to standard of care, a media release from MedRhythms explains.

United statesBrian harrisEric klawiterRon hirschbergNational multiple sclerosis societyMassachusetts general hospitalRhythmic auditory stimulationCleveland clinicCo principal investigatorsMultiple sclerosisNeuromyelitis optica unitஒன்றுபட்டது மாநிலங்களில்பிரையன் ஹாரிஸ்ரோன் ிர்ஸ்ச்பேர்க்தேசிய பல ஸ்க்லரோசிஸ் சமூகம்மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை